Clinical Trials Directory

Trials / Completed

CompletedNCT05586880

Study to Evaluate Efficacy of EnXtra on Accuracy & Reaction Time, Perceived Alertness & Digital Fatigue for Video Gamers

A Randomized, Placebo-controlled, Double-blind Crossover Study to Evaluate Efficacy of EnXtra on Accuracy & Reaction Time, Perceived Alertness & Digital Fatigue for Video Gamers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Vedic Lifesciences Pvt. Ltd. · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In the present study, Sponsor aim to evaluate the effects of EnXtra® as to improve Accuracy \& Reaction Time, Perceived Alertness \& Digital Fatigue for Video Gamers. A Randomized, Placebo-controlled, Double-blind Crossover Study of 60 randomized cross over for total study duration of approximately 25 days with 5 days of treatment period for each arm and 5-7 days wash out period between both arms.

Conditions

Interventions

TypeNameDescription
OTHERExperimental: EnXtra 300 mg/ capsuleOne capsule to be taken 3±0.5 hours prior to second gaming session on Day 1 followed by 1 capsule daily after breakfast for 5 days
OTHERMicrocrystalline cellulose (MCC) 300mgOne capsule to be taken 3±0.5 hours prior to second gaming session on Day 1 followed by 1 capsule daily after breakfast for 5 days

Timeline

Start date
2022-10-10
Primary completion
2023-01-28
Completion
2023-01-28
First posted
2022-10-19
Last updated
2023-03-24

Locations

2 sites across 1 country: India

Source: ClinicalTrials.gov record NCT05586880. Inclusion in this directory is not an endorsement.